New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Researchers recommend all women with breast cancer diagnosis under age 66

Researchers recommend all women with breast cancer diagnosis under age 66

by Joe Dangor,Mayo ClinicCredit: CC0 Public DomainA study by researchers at Mayo Clinic published this week in theJournal of Clinical Oncologysuggests that all women with a breast ca
World medicine December 11,2023
Researchers recommend all women with breast cancer diagnosis under age 66

Researchers recommend all women with breast cancer diagnosis under age 66

by Joe Dangor,Mayo ClinicCredit: CC0 Public DomainA study by researchers at Mayo Clinic published this week in theJournal of Clinical Oncologysuggests that all women with a breast ca
World medicine December 11,2023
Expanding the impact of CAR T cell therapy: An immunotherapy strategy against all blood cancers

Expanding the impact of CAR T cell therapy: An immunotherapy strategy against all blood cancers

byPerelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainA broad new strategy could hold hope for treating virtually all blood cancers with CAR T cell therapy, whi
World medicine December 11,2023
Expanding the impact of CAR T cell therapy: An immunotherapy strategy against all blood cancers

Expanding the impact of CAR T cell therapy: An immunotherapy strategy against all blood cancers

byPerelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainA broad new strategy could hold hope for treating virtually all blood cancers with CAR T cell therapy, whi
World medicine December 11,2023
New results on the function of the tumor suppressor HERC protein

New results on the function of the tumor suppressor HERC protein

byUniversity of BarcelonaCredit: CC0 Public DomainThe RAF protein could be a therapeutical target to treat tumor growth in regulated pathways by the p38 protein, according to a new study publish
World medicine December 11,2023
New results on the function of the tumor suppressor HERC protein

New results on the function of the tumor suppressor HERC protein

byUniversity of BarcelonaCredit: CC0 Public DomainThe RAF protein could be a therapeutical target to treat tumor growth in regulated pathways by the p38 protein, according to a new study publish
World medicine December 11,2023
Tethering of shattered chromosomal fragments paves way for new cancer therapies

Tethering of shattered chromosomal fragments paves way for new cancer therapies

byUniversity of California - San DiegoFragments of micronuclear chromosomal DNA (green) are tethered together in normal conditions (center), but degrading one of the tether proteins prevents thi
World medicine December 11,2023
Tethering of shattered chromosomal fragments paves way for new cancer therapies

Tethering of shattered chromosomal fragments paves way for new cancer therapies

byUniversity of California - San DiegoFragments of micronuclear chromosomal DNA (green) are tethered together in normal conditions (center), but degrading one of the tether proteins prevents thi
World medicine December 11,2023
Younger cancer survivors far more likely to experience food and financial insecurity

Younger cancer survivors far more likely to experience food and financial insecurity

by National Comprehensive Cancer NetworkNew research from the American Cancer Society in the March 2020 issue of JNCCN--Journal of the National Comprehensive Cancer Network finds that younger cancer s
World medicine December 11,2023
Younger cancer survivors far more likely to experience food and financial insecurity

Younger cancer survivors far more likely to experience food and financial insecurity

by National Comprehensive Cancer NetworkNew research from the American Cancer Society in the March 2020 issue of JNCCN--Journal of the National Comprehensive Cancer Network finds that younger cancer s
World medicine December 11,2023
Oral agent found to produce high response rate in patients with multiple myeloma when combined with steroid

Oral agent found to produce high response rate in patients with multiple myeloma when combined with steroid

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainA new agent that subverts myeloma cells from within while also subjecting them to an immune system attack produced impressive resp
World medicine December 11,2023
Oral agent found to produce high response rate in patients with multiple myeloma when combined with steroid

Oral agent found to produce high response rate in patients with multiple myeloma when combined with steroid

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainA new agent that subverts myeloma cells from within while also subjecting them to an immune system attack produced impressive resp
World medicine December 11,2023
Researchers identify marker that may predict whether lung cancer likely to spread

Researchers identify marker that may predict whether lung cancer likely to spread

byTulane UniversityTony Hu is the Weatherhead Presidential Chair in Biotechnology Innovation at Tulane University School of Medicine. Credit: Paula Burch-CelentanoNon-small cell lung cancer (NSC
World medicine December 11,2023
Researchers identify marker that may predict whether lung cancer likely to spread

Researchers identify marker that may predict whether lung cancer likely to spread

byTulane UniversityTony Hu is the Weatherhead Presidential Chair in Biotechnology Innovation at Tulane University School of Medicine. Credit: Paula Burch-CelentanoNon-small cell lung cancer (NSC
World medicine December 11,2023
No cancer risk found at nuclear bases so far, Air Force says

No cancer risk found at nuclear bases so far, Air Force says

by Tara CoppIn this image provided by the U.S. Air Force, Airman 1st Class Jackson Ligon, left, and Senior Airman Jonathan Marinaccio, 341st Missile Maintenance Squadron technicians, connect a re-entr
World medicine December 11,2023
No cancer risk found at nuclear bases so far, Air Force says

No cancer risk found at nuclear bases so far, Air Force says

by Tara CoppIn this image provided by the U.S. Air Force, Airman 1st Class Jackson Ligon, left, and Senior Airman Jonathan Marinaccio, 341st Missile Maintenance Squadron technicians, connect a re-entr
World medicine December 11,2023
Scientists identify first invasive case of rare mold in a cancer patient

Scientists identify first invasive case of rare mold in a cancer patient

by City of HopeCredit: CC0 Public DomainCity of Hope scientists have found a toxic fungus previously thought to not be infectious in the sinus tissues of a man with refractory acute lymphocytic leukem
World medicine December 11,2023
Scientists identify first invasive case of rare mold in a cancer patient

Scientists identify first invasive case of rare mold in a cancer patient

by City of HopeCredit: CC0 Public DomainCity of Hope scientists have found a toxic fungus previously thought to not be infectious in the sinus tissues of a man with refractory acute lymphocytic leukem
World medicine December 11,2023
New clinical tool for clonal hematopoiesis identifies patients at high risk for blood cancer

New clinical tool for clonal hematopoiesis identifies patients at high risk for blood cancer

byDana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainA new clinical tool developed by a team of researchers led by the Dana-Farber Cancer Institute pinpoints which Clonal hematopoiesis
World medicine December 11,2023
New clinical tool for clonal hematopoiesis identifies patients at high risk for blood cancer

New clinical tool for clonal hematopoiesis identifies patients at high risk for blood cancer

byDana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainA new clinical tool developed by a team of researchers led by the Dana-Farber Cancer Institute pinpoints which Clonal hematopoiesis
World medicine December 11,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com